Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 4
2005 5
2006 3
2007 2
2008 2
2009 2
2010 4
2011 4
2012 9
2013 10
2014 5
2015 8
2016 7
2017 8
2018 9
2019 13
2020 17
2021 12
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

123 results
Results by year
Filters applied: . Clear all
Page 1
Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes.
Evans M, Hicks D, Patel D, Patel V, McEwan P, Dashora U. Evans M, et al. Diabetes Ther. 2020 Jan;11(1):37-52. doi: 10.1007/s13300-019-00728-6. Epub 2019 Dec 7. Diabetes Ther. 2020. PMID: 31813092 Free PMC article. Review.
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes.
Wheeler DC, James J, Patel D, Viljoen A, Ali A, Evans M, Fernando K, Hicks D, Milne N, Newland-Jones P, Wilding J; as part of the Improving Diabetes Steering Committee. Wheeler DC, et al. Among authors: evans m. Diabetes Ther. 2020 Dec;11(12):2757-2774. doi: 10.1007/s13300-020-00930-x. Epub 2020 Sep 29. Diabetes Ther. 2020. PMID: 32996085 Free PMC article. Review.
Clinical use of insulin degludec.
Vora J, Cariou B, Evans M, Gross JL, Harris S, Landstedt-Hallin L, Mithal A, Rodriguez MR, Meneghini L. Vora J, et al. Among authors: evans m. Diabetes Res Clin Pract. 2015 Jul;109(1):19-31. doi: 10.1016/j.diabres.2015.04.002. Epub 2015 Apr 14. Diabetes Res Clin Pract. 2015. PMID: 25963320 Free article. Review.
123 results